Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.

MLA

Chang, Susan, et al. “Phase III Randomized Study of Radiation and Temozolomide versus Radiation and Nitrosourea Therapy for Anaplastic Astrocytoma: Results of NRG Oncology RTOG 9813.” Neuro-Oncology, 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1391600130&authtype=sso&custid=ns315887.

APA

Chang, S., Chang, S., Zhang, P., Cairncross, J. G., Gilbert, M. R., Bahary, J.-P., Dolinskas, C. A., Chakravarti, A., Aldape, K. D., Bell, E. H., Schiff, D., Jaeckle, K., Brown, P. D., Barger, G. R., Werner-Wasik, M., Shih, H., Brachman, D., Penas-Prado, M., Robins, H. I., … Mehta, M. (2017). Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813. Neuro-Oncology.

Chicago

Chang, Susan, Susan Chang, Peixin Zhang, J Gregory Cairncross, Mark R Gilbert, Jean-Paul Bahary, Carol A Dolinskas, et al. 2017. “Phase III Randomized Study of Radiation and Temozolomide versus Radiation and Nitrosourea Therapy for Anaplastic Astrocytoma: Results of NRG Oncology RTOG 9813.” Neuro-Oncology. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1391600130&authtype=sso&custid=ns315887.